CNPAX
Price
$66.32
Change
-$0.80 (-1.19%)
Updated
Jun 13 closing price
Net Assets
150.58B
LSGGX
Price
$22.80
Change
-$0.19 (-0.83%)
Updated
Jun 13 closing price
Net Assets
130.66M
Interact to see
Advertisement

CNPAX vs LSGGX

Header iconCNPAX vs LSGGX Comparison
Open Charts CNPAX vs LSGGXBanner chart's image
American Funds New Perspective 529A
Price$66.32
Change-$0.80 (-1.19%)
VolumeN/A
Net Assets150.58B
Loomis Sayles Global Growth Y
Price$22.80
Change-$0.19 (-0.83%)
VolumeN/A
Net Assets130.66M
CNPAX vs LSGGX Comparison Chart
Loading...
View a ticker or compare two or three
VS
CNPAX vs. LSGGX commentary
Jun 16, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNPAX is a Buy and LSGGX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
CNPAX has more cash in the bank: 151B vs. LSGGX (131M). CNPAX pays higher dividends than LSGGX: CNPAX (0.51) vs LSGGX (0.00). CNPAX was incepted earlier than LSGGX: CNPAX (23 years) vs LSGGX (9 years). LSGGX (1.13) is less costly to investors than CNPAX (0.77). CNPAX is a more actively managed with annual turnover of: 24.00 vs. LSGGX (6.00). CNPAX has a lower initial minimum investment than LSGGX: CNPAX (250) vs LSGGX (100000). LSGGX annual gain was more profitable for investors over the last year : 23.38 vs. CNPAX (8.81). LSGGX (49.80) and CNPAX (48.94) have equivalent 5 years return.
CNPAXLSGGXCNPAX / LSGGX
Total Expense Ratio0.770.9581%
Annual Report Gross Expense Ratio0.771.1368%
Fund Existence23 years9 years-
Gain YTD8.6688.93597%
Front Load4%N/A-
Min. Initial Investment2501000000%
Min. Initial Investment IRAN/AN/A-
Net Assets151B131M115,267%
Annual Yield % from dividends0.510.00-
Returns for 1 year8.8123.3838%
Returns for 3 years43.8079.1055%
Returns for 5 years48.9449.8098%
Returns for 10 years84.23N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CSBR7.660.26
+3.58%
Champions Oncology
ARTL7.200.11
+1.56%
Artelo Biosciences Inc
PRGS62.62-0.62
-0.98%
Progress Software Corp
CDNA18.59-0.24
-1.27%
CareDx
CYBR386.69-5.43
-1.38%
CyberArk Software Ltd